Optimind Pharma Corp. (OMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
(Values in thousands)
| 08-2025 | 05-2025 | 02-2025 | 11-2024 | 08-2024 | |
| Sales | 27 | 36 | 35 | 27 | 41 |
| Operating Expenses | 38 | 36 | 61 | 36 | 124 |
| Operating Income | -11 | 0 | -27 | -9 | -83 |
| Pre-tax Income | -11 | 0 | -27 | -9 | -83 |
| Net Income Continuous | -11 | 0 | -27 | -9 | -83 |
| Net Income | $-11 | $0 | $-27 | $-9 | $-83 |
| EBITDA(a) | $-11 | $0 | $-27 | $-9 | $-83 |